ARCHIVES

Collaborative Drug Development Groups Clear BSC Overview, Natural Products RFA To Proceed

This article is from The Cancer Letter archive.

Vol. 14 No. 24 | June 10, 1988

Download PDF Visit The Full Archive

Related Articles

RFAs Available

February 23, 1996

Tobacco Council awards $10 Million In 1986

August 14, 1987

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

March 15, 1991

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

Watson Steps Down As Chancellor at Cold Spring Harbor Laboratory.

October 26, 2007